tiprankstipranks
Trending News
More News >
Arbutus Biopharma Corporation (ABUS)
NASDAQ:ABUS

Arbutus Biopharma (ABUS) Revenue

Compare
1,235 Followers

Arbutus Biopharma Revenue

Arbutus Biopharma had a revenue of 1.57M in the quarter ending Dec 31, 2024, with 17.55%. This bring the company's revenue in the last twelve months to 6.17M, Increased -8.47%. In the fiscal year ending Dec 31, 2024, Arbutus Biopharma had annual revenue of 6.17M with -65.98% growth.
Revenue (ttm)
6.17M
Revenue Growth
-65.98%
P/S Ratio
94.95
Revenue/Employee
$140,250
Employees
44
Market Cap
$585.93M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 20246.17M-11.97M-65.98%
Dec 31, 202318.14M-20.88M-53.51%
Dec 31, 202239.02M28.03M+255.11%
Dec 31, 202110.99M4.07M+58.92%
Dec 31, 20206.91M903.00K+15.02%
Dec 31, 20196.01M111.00K+1.88%
Dec 31, 20185.90M-4.80M-44.86%
Dec 31, 201710.70M9.20M+613.33%
Dec 31, 20161.50M-23.37M-93.97%
Dec 31, 201524.87M9.87M+65.82%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis